Angioplasty Balloons Market Size & Share Normal Angioplasty Balloons: The normal angioplasty balloons segment holds a significant share in the market due to their widespread use in various applications such as peripheral and coronary interventions. These balloons provide support in dilating the narrowed or blocked arteries, thereby improving blood flow. Drug-Eluting Balloons (DEB): The DEB segment is expected to witness a high growth rate in the market, attributed to their ability to deliver anti-proliferative drugs directly to the target site, reducing the risk of restenosis. The increasing adoption of DEBs in coronary and peripheral interventions is fueling the segment's growth. Cutting Angioplasty Balloons: Cutting angioplasty balloons are designed with microsurgical-like blades to remove the plaque from the artery walls during the procedure. This segment is gaining traction in the market as it provides a more precise and efficient method of plaque removal compared to traditional angioplasty balloons. Scoring Angioplasty Balloons: Scoring angioplasty balloons segment is also witnessing growth, primarily driven by their ability to create grooves in the plaque, facilitating better expansion and establishment of stent apposition. These balloons are increasingly used in complex coronary interventions, contributing to the segment's market share. Peripheral Application: The peripheral application segment dominates the market share, attributed to the rising prevalence of peripheral artery disease (PAD) and the increasing demand for minimally invasive procedures to treat these conditions. Angioplasty balloons are extensively used in peripheral interventions, contributing to the segment's growth. Coronary Application: The coronary application segment is also witnessing significant growth in the market, driven by the increasing incidence of coronary artery disease (CAD) and the advancements in angioplasty techniques. The demand for coronary angioplasty balloons is on the rise, particularly in cath labs and hospitals. Hospitals End-use: Hospitals are the major end-users of angioplasty balloons, owing to the high patient footfall for cardiovascular interventions and the availability of advanced medical facilities. The hospitals segment holds a significant market share and is expected to continue its dominance in the coming years. Ambulatory Surgical Centers (ASCs): ASCs are gaining traction as end-users of angioplasty balloons, attributed to their cost-effective nature and convenience for patients undergoing minimally invasive procedures. The ASCs segment is expected to witness steady growth in the market share, driven by the increasing preference for outpatient settings for cardiovascular interventions. Cath Labs: Cath labs play a crucial role in performing angioplasty procedures, particularly in diagnostic and interventional cardiology. The cath labs segment holds a substantial share in the market, supported by the increasing number of catheterization procedures and the growing investment in advanced cath lab equipment.